Stay updated with breaking news from Celularity Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Celularity Inc. (NASDAQ:CELUW – Get Rating) was the target of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 14,000 shares, an increase of 30.8% from the March 31st total of 10,700 shares. Based on an average daily volume of 20,500 shares, the short-interest […]
Inhibitor Therapeutics (OTCMKTS:INTI – Get Rating) and Celularity (NASDAQ:CELU – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations. Risk and Volatility Inhibitor Therapeutics has a beta of -0.46, […]
Celularity Inc. (NASDAQ:CELU – Get Rating) was the recipient of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 5,170,000 shares, an increase of 8.8% from the March 15th total of 4,750,000 shares. Based on an average daily volume of 570,100 shares, the days-to-cover […]
Celularity Inc. (NASDAQ:CELU – Get Rating) was the recipient of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 5,170,000 shares, a growth of 8.8% from the March 15th total of 4,750,000 shares. Approximately 7.4% of the company’s shares are short sold. Based on […]
Item 1.01 Entry into a Material Definitive Agreement. Registered Direct Offering On April 4, 2023, Celularity Inc, or Celularity, entered into a securities purchase agreement with an institutional... | April 7, 2023